WC
GILD icon

Weil Company’s Gilead Sciences GILD Stock Holding History

Weil Company’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-16,530
Closed -$1.2M – 133
2021
Q4 		$1.2M Buy
16,530
+875
+6% +$60.3K 0.56% 47
2021
Q3 		$1.09M Buy
15,655
+77
+0.5% +$5.41K 0.57% 49
2021
Q2 		$1.07M Buy
15,578
+5,385
+53% +$360K 0.54% 51
2021
Q1 		$659K Buy
10,193
+285
+3% +$18.4K 0.37% 70
2020
Q4 		$577K Buy
9,908
+244
+3% +$14.7K 0.35% 71
2020
Q3 		$611K Buy
9,664
+1,468
+18% +$102K 0.45% 53
2020
Q2 		$631K Buy
8,196
+3,790
+86% +$290K 0.53% 42
2020
Q1 		$329K Buy
4,406
+1,059
+32% +$73.2K 0.31% 60
2019
Q4 		$217K Buy
3,347
+86
+3% +$5.6K 0.17% 98
2019
Q3 		$207K Buy
+3,261
New +$213K 0.15% 90

Other funds holding GILD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Weil Company's GILD Position: Q1 2022 in Review

Weil Company sold out of Gilead Sciences (GILD) in Q1 2022, closing a stake of 16,530 shares — an estimated $1.2M sold.

Weil Company first reported a position in GILD in Q3 2019 and held it in 10 quarters. The position peaked at $1.2M in Q4 2021. 1,600 funds tracked by Wall St. Rank hold GILD as of Q1 2022.

  • Weil Company reported no remaining Gilead Sciences position as of Q1 2022 after selling out during the quarter.
  • Weil Company sold 16,530 Gilead Sciences shares in Q1 2022, an estimated $1.2M.
  • Weil Company first reported a position in Gilead Sciences in Q3 2019 and held it in 10 quarters.
  • Weil Company's Gilead Sciences position peaked at $1.2M in Q4 2021.
  • 1,600 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2022.

Based on Weil Company's 13F filing for Q1 2022, filed 6 May 2022.